{"id":"W4281285399","doi":"10.1002/ajh.26618","title":"Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia","year":2022,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Myeloid leukemia; Population; Cancer registry; Cancer; Internal medicine; Oncology; Incidence (geometry); Leukemia; Tyrosine-kinase inhibitor; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01089469,0.0003548793,0.001431401,0.0009312686,0.0009736272,0.002351643,0.00144392,0.004748838,0.004406123],"category_scores_gemma":[0.03778963,0.0002597896,0.001221266,0.0009470671,0.001495194,0.002644978,0.0006174225,0.00942158,0.004257477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006946331,"about_ca_system_score_gemma":0.001538364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001441879,"about_ca_topic_score_gemma":0.003334049,"domain_scores_codex":[0.9925061,0.003534865,0.001474169,0.0005587208,0.001743447,0.0001826055],"domain_scores_gemma":[0.9747291,0.01641473,0.002503074,0.001548949,0.003773652,0.001030558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001917719,0.0003522801,0.02565166,0.004891002,0.0005175489,0.01596962,0.003294088,0.0004364567,0.006559863,0.0083671,0.4786343,0.4534083],"study_design_scores_gemma":[0.0002322202,0.000640213,0.01335924,0.0042191,0.0003627061,0.027388,0.001690582,0.0005910427,0.004538966,0.01134567,0.935518,0.0001142865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.05775506,0.2437369,0.0213538,0.5922341,0.03337796,0.0003433931,0.001275737,0.001176642,0.0487465],"genre_scores_gemma":[0.2680598,0.08674718,0.04778656,0.528918,0.04900875,0.0005630648,0.0007278536,0.0005819825,0.01760691],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.01089469,"threshold_uncertainty_score":0.05761731,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02980958234156228,"score_gpt":0.2920588869648335,"score_spread":0.2622493046232712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}